Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin with or without compound salvia miltiorrhiza for INR stability and warfarin pharmacokinetics
ChiCTR-IPR-15006624Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial comparing Warfarin + compound salvia miltiorrhiza with Warfarin (2 arms). Primary endpoints: Warfarin plasma concentration and Coagulation testing. Started Jun 2015; status: recruiting.
02
Drugs
warfarinCompound Danshen
Beyond the preview
Go deeper on ChiCTR-IPR-15006624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006624.